MEI Pharma Secures Over $100 Million Funding Commitment to Launch Litecoin Treasury Strategy
BlockBeats News, July 19th, Titan Partners Group and crypto investment firm GSR are co-leading a strategic transformation of the US pharmaceutical company MEI Pharma (NASDAQ: MEIP), driving the establishment of a dedicated Litecoin treasury strategy. Currently, there has been over $100 million in funding commitments to this project.
It is worth mentioning that Litecoin creator Charlie Lee has agreed to join the MEI Pharma board of directors. Furthermore, the Litecoin Foundation has also invested in MEI Pharma as the company's treasury strategy aligns closely with the Litecoin Foundation's core mission of promoting global Litecoin adoption.
You may also like
Gainers
Latest Crypto News
「Whale」 Continuously Added to ETH Long Position for Nearly 2 Hours, Increasing Holdings to $8.8 Million
The US Military Experiences an Investment Craze, with Cryptocurrency and Tech Stocks as the Main Investment Focus
Rayls Airdrop Claiming is Now Live
Tom Lee's Fund Analyst: Crypto Has Entered a Two-Month "High Risk-Reward" Window
Solana Ecosystem's OG Meme Coin Sees Strong Rebound Today, ZEREBRO Surges Over 35%
Customer Support:@weikecs
Business Cooperation:@weikecs
Quant Trading & MM:[email protected]
VIP Services:[email protected]